Science 23 March 1984: Vol. 223. no. 4642, pp. 1296 - 1299 DOI: 10.1126/science.6199844

Prev | Table of Contents | Next

Articles

Effect of FGF-binding Protein 3 on Vascular Permeability.

W. Zhang, Y. Chen, M. R. Swift, E. Tassi, D. C. Stylianou, K. A. Gibby, A. T. Riegel, and A. Wellstein (2008)
J. Biol. Chem. 283, 28329-28337
 |  Abstract »  |  Full Text »  |  PDF »

FGF signals guide migration of mesenchymal cells, control skeletal morphogenesis and regulate gastrulation during sea urchin development.

E. Rottinger, A. Saudemont, V. Duboc, L. Besnardeau, D. McClay, and T. Lepage (2008)
Development 135, 353-365
 |  Abstract »  |  Full Text »  |  PDF »

Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers.

C. Widakowich, G. de Castro Jr., E. de Azambuja, P. Dinh, and A. Awada (2007)
Oncologist 12, 1443-1455
 |  Abstract »  |  Full Text »  |  PDF »

{alpha}A-crystallin expression prevents {gamma}-crystallin insolubility and cataract formation in the zebrafish cloche mutant lens.

K. Goishi, A. Shimizu, G. Najarro, S. Watanabe, R. Rogers, L. I. Zon, and M. Klagsbrun (2006)
Development 133, 2585-2593
 |  Abstract »  |  Full Text »  |  PDF »

Antiangiogenic Therapy for Cancer: from the Bench to Bedside and Back.

J. V. Heymach (2006)
Am. Assoc. Cancer Res. Educ. Book 2006, 177-180
 |  Full Text »  |  PDF »

Profile of Plasma Angiogenic Factors Before and After Hepatectomy for Colorectal Cancer Liver Metastases.

S. S. Yoon, S. H. Kim, M. Gonen, N. M. Heffernan, K. Y. Detwiller, W. R. Jarnagin, M. D'Angelica, L. H. Blumgart, K. K. Tanabe, and R. P. DeMatteo (2006)
Ann. Surg. Oncol. 13, 353-362
 |  Abstract »  |  Full Text »  |  PDF »

Prox1 Promotes Lineage-specific Expression of Fibroblast Growth Factor (FGF) Receptor-3 in Lymphatic Endothelium: A Role for FGF Signaling in Lymphangiogenesis.

J. W. Shin, M. Min, F. Larrieu-Lahargue, X. Canron, R. Kunstfeld, L. Nguyen, J. E. Henderson, A. Bikfalvi, M. Detmar, and Y.-K. Hong (2006)
Mol. Biol. Cell 17, 576-584
 |  Abstract »  |  Full Text »  |  PDF »

The axonal attractant Netrin-1 is an angiogenic factor.

K. W. Park, D. Crouse, M. Lee, S. K. Karnik, L. K. Sorensen, K. J. Murphy, C. J. Kuo, and D. Y. Li (2004)
PNAS 101, 16210-16215
 |  Abstract »  |  Full Text »  |  PDF »

Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma.

S. S. Yoon, N. H. Segal, A. B. Olshen, M. F. Brennan, and S. Singer (2004)
Ann. Onc. 15, 1261-1266
 |  Abstract »  |  Full Text »  |  PDF »

Polyanions and the Proteome.

L. S. Jones, B. Yazzie, and C. R. Middaugh (2004)
Mol. Cell. Proteomics 3, 746-769
 |  Abstract »  |  Full Text »  |  PDF »

Perlecan and Tumor Angiogenesis.

X. Jiang and J. R. Couchman (2003)
J. Histochem. Cytochem. 51, 1393-1410
 |  Abstract »  |  Full Text »  |  PDF »

Heparin and Angiogenesis: Size Matters!.

J. Rak and J. I. Weitz (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 1954-1955
 |  Full Text »  |  PDF »

Nuclear Translocation of Phosphorylated STAT3 Is Essential for Vascular Endothelial Growth Factor-induced Human Dermal Microvascular Endothelial Cell Migration and Tube Formation.

Y. Yahata, Y. Shirakata, S. Tokumaru, K. Yamasaki, K. Sayama, Y. Hanakawa, M. Detmar, and K. Hashimoto (2003)
J. Biol. Chem. 278, 40026-40031
 |  Abstract »  |  Full Text »  |  PDF »

Angiostatin4.5-mediated Apoptosis of Vascular Endothelial Cells.

H. A. Hanford, C. A. Wong, H. Kassan, D. L. Cundiff, N. Chandel, S. Underwood, C. A. Mitchell, and G. A. Soff (2003)
Cancer Res. 63, 4275-4280
 |  Abstract »  |  Full Text »  |  PDF »

Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis.

R. Giavazzi, B. Sennino, D. Coltrini, A. Garofalo, R. Dossi, R. Ronca, M. P. M. Tosatti, and M. Presta (2003)
Am. J. Pathol. 162, 1913-1926
 |  Abstract »  |  Full Text »  |  PDF »

Retinal Vascular Development Is Mediated by Endothelial Filopodia, a Preexisting Astrocytic Template and Specific R-Cadherin Adhesion.

M. I. Dorrell, E. Aguilar, and M. Friedlander (2002)
Invest. Ophthalmol. Vis. Sci. 43, 3500-3510
 |  Abstract »  |  Full Text »  |  PDF »

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

H. Kubo, R. Cao, E. Brakenhielm, T. Makinen, Y. Cao, and K. Alitalo (2002)
PNAS 99, 8868-8873
 |  Abstract »  |  Full Text »  |  PDF »

HIF-1{alpha}-mediated Up-Regulation of Vascular Endothelial Growth Factor, Independent of Basic Fibroblast Growth Factor, Is Important in the Switch to the Angiogenic Phenotype during Early Tumorigenesis.

J. Fang, L. Yan, Y. Shing, and M. A. Moses (2001)
Cancer Res. 61, 5731-5735
 |  Abstract »  |  Full Text »  |  PDF »

Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer.

N. C. Levitt, F. A. L. M. Eskens, K. J. O'Byrne, D. J. Propper, L. J. Denis, S. J. Owen, L. Choi, J. A. Foekens, S. Wilner, J. M. Wood, et al. (2001)
Clin. Cancer Res. 7, 1912-1922
 |  Abstract »  |  Full Text »  |  PDF »

Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors.

R. Giavazzi, R. Giuliani, D. Coltrini, M. R. Bani, C. Ferri, B. Sennino, M. P. M. Tosatti, A. Stoppacciaro, and M. Presta (2001)
Cancer Res. 61, 309-317
 |  Abstract »  |  Full Text »

Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation.

A. W. Griffioen and G. Molema (2000)
Pharmacol. Rev. 52, 237-268
 |  Abstract »  |  Full Text »  |  PDF »

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.

J. Fang, Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, G. Jackson, J. Harper, G. Tamvakopoulos, and M. A. Moses (2000)
PNAS 97, 3884-3889
 |  Abstract »  |  Full Text »  |  PDF »

Tumor angiogenesis: past, present and the near future.

R. S. Kerbel (2000)
Carcinogenesis 21, 505-515
 |  Abstract »  |  Full Text »  |  PDF »

Heparin and angiogenic therapy.

M. Fujita (2000)
Eur. Heart J. 21, 270-274
 |  PDF »

Mitogenic Effects of Fibroblast Growth Factors on Chicken Granulosa and Theca Cells In Vitro.

R. D. Roberts and R. C.L. Ellis (1999)
Biol Reprod 61, 1387-1392
 |  Abstract »  |  Full Text »

Endothelial-Monocyte Activating Polypeptide II, A Novel Antitumor Cytokine that Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells.

M. A. Schwarz, J. Kandel, J. Brett, J. Li, J. Hayward, R. E. Schwarz, O. Chappey, J.-L. Wautier, J. Chabot, P. L. Gerfo, et al. (1999)
J. Exp. Med. 190, 341-354
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins.

S. M. Hyder and G. M. Stancel (1999)
Mol. Endocrinol. 13, 806-811
 |  Full Text »

Synthesis and Anticoagulant Properties of a Novel Heparinoid N-Sulfate-Bearing Vinylpolymer.

N. Sakamoto, T. Yumura, M. Akashi, and M. Onishi (1999)
Journal of Bioactive and Compatible Polymers 14, 150-161
 |  Abstract »  |  PDF »

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells.

C. M. Satterwhite, A. M. Farrelly, and M. E. Bradley (1999)
Am J Physiol Heart Circ Physiol 276, H1091-H1097
 |  Abstract »  |  Full Text »  |  PDF »

Expression of chicken fibroblast growth factor homologous factor (FHF)-1 and of differentially spliced isoforms of FHF-2 during development and involvement of FHF-2 in chicken limb development.

I Munoz-Sanjuan, B. Simandl, J. Fallon, and J Nathans (1999)
Development 126, 409-421
 |  Abstract »  |  PDF »

Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.

W.-r. Ji, F. J. Castellino, Y. Chang, M. E. Deford, H. Gray, X. Villarreal, M. E. Kondri, D. N. Marti, M. Llinás, J. Schaller, et al. (1998)
FASEB J 12, 1731-1738
 |  Abstract »  |  Full Text »

Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.

M A Hull, J L Brough, D G Powe, G I Carter, D Jenkins, and C J Hawkey (1998)
Gut 43, 525-536
 |  Abstract »  |  Full Text »  |  PDF »

Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle.

B. H. Annex, C. E. Torgan, P. Lin, D. A. Taylor, M. A. Thompson, K. G. Peters, and W. E. Kraus (1998)
Am J Physiol Heart Circ Physiol 274, H860-H867
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenic Therapy of the Human Heart.

J. Folkman (1998)
Circulation 97, 628-629
 |  Full Text »  |  PDF »

A Major Common Trisulfated Hexasaccharide Core Sequence, Hexuronic Acid(2-Sulfate)-Glucosamine(N-Sulfate)-Iduronic Acid-N-Acetylglucosamine-Glucuronic Acid-Glucosamine(N-Sulfate), Isolated from the Low Sulfated Irregular Region of Porcine Intestinal Heparin.

S. Yamada, Y. Yamane, H. Tsuda, K. Yoshida, and K. Sugahara (1998)
J. Biol. Chem. 273, 1863-1871
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?.

B. S Lewis, M. Y Flugelman, A. Weisz, I. Keren-Tal, and W. Schaper (1997)
Cardiovasc Res 35, 490-497
 |  Abstract »  |  Full Text »  |  PDF »

In Vitro Assessment of the Biological Activity of Basic Fibroblast Growth Factor Released from Various Polymers and Biomatrices.

M. J. Davies, C. A. Mitchell, M. A. L. Maley, M. D. Grounds, A. R. Harvey, G. W. Plant, D. J. Wood, Y. Hong, and T. V. Chirila (1997)
J Biomater Appl 12, 31-56
 |  Abstract »  |  PDF »

Interaction of Heparin with Human Angiogenin.

F. Soncin, D. J. Strydom, and R. Shapiro (1997)
J. Biol. Chem. 272, 9818-9824
 |  Abstract »  |  Full Text »  |  PDF »

CD44-Hyaluronate Interaction Participates in the Adherence of T-lymphocytes to Gingival Fibroblasts.

S. Murakami, T. Saho, A. Asari, E. Hino, D. Kasai, Y. Shimabukuro, and H. Okada (1996)
Journal of Dental Research 75, 1545-1552
 |  Abstract »  |  PDF »

Heparin-Binding Epidermal Growth Factor-Like Growth Factor Regulates Fibroblast Growth Factor-2 Expression in Aortic Smooth Muscle Cells.

K. A. Peifley, G. F. Alberts, D. K.W. Hsu, S.-L. Y. Feng, and J. A. Winkles (1996)
Circ. Res. 79, 263-270
 |  Abstract »  |  Full Text »

Structures of Five Sulfated Hexasaccharides Prepared from Porcine Intestinal Heparin Using Bacterial Heparinase.

H. Tsuda, S. Yamada, Y. Yamane, K. Yoshida, J. J. Hopwood, and K. Sugahara (1996)
J. Biol. Chem. 271, 10495-10502
 |  Abstract »  |  Full Text »  |  PDF »

Structure Determination of the Octa- and Decasaccharide Sequences Isolated from the Carbohydrate-Protein Linkage Region of Porcine Intestinal Heparin.

K. Sugahara, H. Tsuda, K. Yoshida, S. Yamada, T. de Beer, and J. F. G. Vliegenthart (1995)
J. Biol. Chem. 270, 22914-22923
 |  Abstract »  |  Full Text »  |  PDF »

Glu-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding.

H. Zhu, K. Ramnarayan, J. Anchin, W. Y. Miao, A. Sereno, L. Millman, J. Zheng, V. N. Balaji, and M. E. Wolff (1995)
J. Biol. Chem. 270, 21869-21874
 |  Abstract »  |  Full Text »  |  PDF »

Arterial Gene Therapy for Therapeutic Angiogenesis in Patients With Peripheral Artery Disease.

J. M. Isner, K. Walsh, J. Symes, A. Pieczek, S. Takeshita, J. Lowry, S. Rossow, K. Rosenfield, L. Weir, E. Brogi, et al. (1995)
Circulation 91, 2687-2692
 |  Full Text »

Interleukin-8 as a macrophage-derived mediator of angiogenesis.

A. Koch, P. Polverini, S. Kunkel, L. Harlow, L. DiPietro, V. Elner, S. Elner, and R. Strieter (1992)
Science 258, 1798-1801
 |  Abstract »  |  PDF »

Capillary endothelial cells secrete a heparin-binding mitogen for pericytes.

J. C. Swinscoe and E. C. Carlson (1992)
J. Cell Sci. 103, 453-461
 |  Abstract »  |  PDF »

A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.

S Higashiyama, J. Abraham, J Miller, J. Fiddes, and M Klagsbrun (1991)
Science 251, 936-939
 |  Abstract »  |  PDF »

Identification of an inhibitor of neovascularization from cartilage.

M. Moses, J Sudhalter, and R Langer (1990)
Science 248, 1408-1410
 |  Abstract »  |  PDF »

Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1.

R. Kaner, A Baird, A Mansukhani, C Basilico, B. Summers, R. Florkiewicz, and D. Hajjar (1990)
Science 248, 1410-1413
 |  Abstract »  |  PDF »

Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle.

J DiMario, N Buffinger, S Yamada, and R. Strohman (1989)
Science 244, 688-690
 |  Abstract »  |  PDF »

The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer.

D Kimelman, J. Abraham, T Haaparanta, T. Palisi, and M. Kirschner (1988)
Science 242, 1053-1056
 |  Abstract »  |  PDF »

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

S Nakamura, S. Salahuddin, P Biberfeld, B Ensoli, P. Markham, F Wong-Staal, and R. Gallo (1988)
Science 242, 426-430
 |  Abstract »  |  PDF »

Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

D. Rappolee, D Mark, M. Banda, and Z Werb (1988)
Science 241, 708-712
 |  Abstract »  |  PDF »

Extracellular Modulating Factors and the Control of Intraocular Neovascularization: An Overview.

B. M. Glaser (1988)
Arch Ophthalmol 106, 603-607
 |  Abstract »  |  PDF »

Angiogenic factors.

J Folkman and M Klagsbrun (1987)
Science 235, 442-447
 |  Abstract »  |  PDF »

Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.

J. Abraham, A Mergia, J. Whang, A Tumolo, J Friedman, K. Hjerrild, D Gospodarowicz, and J. Fiddes (1986)
Science 233, 545-548
 |  Abstract »  |  PDF »

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

A. Schreiber, M. Winkler, and R Derynck (1986)
Science 232, 1250-1253
 |  Abstract »  |  PDF »

Human Basic Fibroblast Growth Factor: Nucleotide Sequence, Genomic Organization, and Expression in Mammalian Cells.

J.A. Abraham, J.L. Whang, A. Tumolo, A. Mergia, and J.C. Fiddes (1986)
Cold Spring Harb Symp Quant Biol 51, 657-668
 |  Abstract »  |  PDF »

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

T Maciag, T Mehlman, R Friesel, and A. Schreiber (1984)
Science 225, 932-935
 |  Abstract »  |  PDF »

A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

A. Otani, B. M. Slike, M. I. Dorrell, J. Hood, K. Kinder, K. L. Ewalt, D. Cheresh, P. Schimmel, and M. Friedlander (2002)
PNAS 99, 178-183
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms of normal and tumor-derived angiogenesis.

M. Papetti and I. M. Herman (2002)
Am J Physiol Cell Physiol 282, C947-C970
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products